Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.
 Back to Details

Connection

Elizabeth David to Lung Neoplasms

This is a "connection" page, showing publications Elizabeth David has written about Lung Neoplasms.

 
Connection Strength
  
 
 
6.428
  
  1. Toubat O, Ding L, Ding K, Wightman SC, Atay SM, Harano T, Kim AW, David EA. Benefit of adjuvant chemotherapy for resected pathologic N1 non-small cell lung cancer is unrecognized: A subgroup analysis of the JBR10 trial. Semin Thorac Cardiovasc Surg. 2024; 36(2):261-270.
    View in: PubMed
    Score: 0.289
  2. Bick KJ, Ding L, Ebner PJ, Kim AW, Atay SM, Wightman SC, McFadden PM, Farias AJ, David EA. Regional Variation in Treatment for Highest-Risk Patients With Non-Small Cell Lung Cancer. Ann Thorac Surg. 2022 04; 113(4):1282-1290.
    View in: PubMed
    Score: 0.261
  3. Liu L, Rwigema JN, Song Z, Cockburn M, Farias AJ, Kim SE, David EA. Assessing Disparities in Lung Cancer Incidence for Gender Minority Individuals Using California Cancer Registry Data. Chest. 2021 06; 159(6):2491-2493.
    View in: PubMed
    Score: 0.254
  4. David EA. Commentary: I Am Happy to Inform You That Thoracotomy Is No Longer Required for Stage IIIA-N2 NSCLC. Semin Thorac Cardiovasc Surg. 2021; 33(2):558.
    View in: PubMed
    Score: 0.252
  5. David EA. Commentary: STAS is here to STAY. J Thorac Cardiovasc Surg. 2022 01; 163(1):287-288.
    View in: PubMed
    Score: 0.251
  6. Shemanski KA, Farias A, Lieu D, Kim AW, Wightman S, Atay SM, Canter RJ, David EA. Understanding thoracic surgeons' perceptions of administrative database analyses and guidelines in clinical decision-making. J Thorac Cardiovasc Surg. 2021 Mar; 161(3):807-816.e1.
    View in: PubMed
    Score: 0.250
  7. Toubat O, Atay SM, Kim AW, Ding L, Farias AJ, Ebner PJ, McFadden PM, David EA. Disparities in Guideline-Concordant Treatment for Pathologic N1 Non-Small Cell Lung Cancer. Ann Thorac Surg. 2020 05; 109(5):1512-1520.
    View in: PubMed
    Score: 0.239
  8. David EA, Atay SM. Commentary: To scan or not to scan: No longer the question for mesothelioma patients after pleurectomy. J Thorac Cardiovasc Surg. 2020 10; 160(4):1076-1077.
    View in: PubMed
    Score: 0.238
  9. Ebner PJ, Ding L, Kim AW, Atay SM, Yao MJ, Toubat O, McFadden PM, Balekian AA, David EA. The Effect of Socioeconomic Status on Treatment and Mortality in Non-Small Cell Lung Cancer Patients. Ann Thorac Surg. 2020 01; 109(1):225-232.
    View in: PubMed
    Score: 0.232
  10. David EA, Atay SM, McFadden PM, Kim AW. Sublobar or Suboptimal: Does Tumor Spread through Air Spaces Signify the End of Sublobar Resections for T1N0 Adenocarcinomas? J Thorac Oncol. 2019 01; 14(1):11-12.
    View in: PubMed
    Score: 0.222
  11. David EA, Andersen SW, Beckett LA, Melnikow J, Clark JM, Brown LM, Cooke DT, Kelly K, Canter RJ. Survival benefits associated with surgery for advanced non-small cell lung cancer. J Thorac Cardiovasc Surg. 2019 04; 157(4):1620-1628.
    View in: PubMed
    Score: 0.220
  12. Brown LM, Cooke DT, Jett JR, David EA. Extent of Resection and Lymph Node Assessment for Clinical Stage T1aN0M0 Typical Carcinoid Tumors. Ann Thorac Surg. 2018 Jan; 105(1):207-213.
    View in: PubMed
    Score: 0.205
  13. Brown LM, Cooke DT, David EA. Adjuvant Chemotherapy Does Not Improve Survival for Lung Cancer With Chest Wall Invasion. Ann Thorac Surg. 2017 Dec; 104(6):1798-1804.
    View in: PubMed
    Score: 0.205
  14. David EA, Andersen SW, Beckett LA, Melnikow J, Kelly K, Cooke DT, Brown LM, Canter RJ. A Model to Predict the Use of Surgical Resection for Advanced-Stage Non-Small Cell Lung Cancer Patients. Ann Thorac Surg. 2017 Nov; 104(5):1665-1672.
    View in: PubMed
    Score: 0.203
  15. David EA, Clark JM, Cooke DT, Melnikow J, Kelly K, Canter RJ. The Role of Thoracic Surgery in the Therapeutic Management of Metastatic Non-Small Cell Lung Cancer. J Thorac Oncol. 2017 11; 12(11):1636-1645.
    View in: PubMed
    Score: 0.202
  16. David EA, Daly ME, Li CS, Chiu CL, Cooke DT, Brown LM, Melnikow J, Kelly K, Canter RJ. Increasing Rates of No Treatment in Advanced-Stage Non-Small Cell Lung Cancer Patients: A Propensity-Matched Analysis. J Thorac Oncol. 2017 03; 12(3):437-445.
    View in: PubMed
    Score: 0.194
  17. David EA, Cooke DT, Chen Y, Nijar K, Canter RJ, Cress RD. Does Lymph Node Count Influence Survival in Surgically Resected Non-Small Cell Lung Cancer? Ann Thorac Surg. 2017 Jan; 103(1):226-235.
    View in: PubMed
    Score: 0.187
  18. David EA, Canter RJ, Chen Y, Cooke DT, Cress RD. Surgical Management of Advanced Non-Small Cell Lung Cancer Is Decreasing But Is Associated With Improved Survival. Ann Thorac Surg. 2016 Oct; 102(4):1101-9.
    View in: PubMed
    Score: 0.186
  19. David EA, Cooke DT, Chen Y, Perry A, Canter RJ, Cress R. Surgery in high-volume hospitals not commission on cancer accreditation leads to increased cancer-specific survival for early-stage lung cancer. Am J Surg. 2015 Oct; 210(4):643-7.
    View in: PubMed
    Score: 0.174
  20. Cooke DT, Gandara DR, Goodwin NC, Calhoun RF, Lara PN, Mack PC, David EA. Outcomes and efficacy of thoracic surgery biopsy for tumor molecular profiling in patients with advanced lung cancer. J Thorac Cardiovasc Surg. 2014 Jul; 148(1):36-40.
    View in: PubMed
    Score: 0.159
  21. David E, Thall PF, Kalhor N, Hofstetter WL, Rice DC, Roth JA, Swisher SG, Walsh GL, Vaporciyan AA, Wei C, Mehran RJ. Visceral pleural invasion is not predictive of survival in patients with lung cancer and smaller tumor size. Ann Thorac Surg. 2013 Jun; 95(6):1872-7; discussion 1877.
    View in: PubMed
    Score: 0.150
  22. Gorbatov ML, Arizpe A, David EA, Liu L, Cockburn M, Farias AJ. Racial and ethnic disparities in receipt of guideline-concordant treatment for early-stage non-small cell lung cancer. Cancer Causes Control. 2026 Jul 01; 37(7).
    View in: PubMed
    Score: 0.093
  23. Mott NM, Meguid RA, Randhawa SK, David EA, Mitchell JD, Stuart CM. Social Vulnerability is Associated with Significant Delays to Definitive Surgery for Stages IA to IIIA Non-small Cell Lung Cancer and Consequential Increased Rates of Pathologic Upstaging. Ann Surg Oncol. 2026 Feb; 33(2):858-870.
    View in: PubMed
    Score: 0.088
  24. Rajaram R, Sheshadri A, Baugh A, Bonnell LN, Li L, Vaporciyan AA, Block M, David EA, Habib RH, Ost DE. Race-Specific versus Race-Neutral Pulmonary Function Predicted Values in Patients with Operable Lung Cancer. Ann Am Thorac Soc. 2025 08; 22(8):1244-1253.
    View in: PubMed
    Score: 0.088
  25. Brascia D, Potenza I, Muto M, David EA, Pompili C. Patient's Participation in Lung Cancer Surgical Treatment: The Role of Patient-Reported Outcomes and Advocacy. Surg Oncol Clin N Am. 2025 10; 34(4):623-635.
    View in: PubMed
    Score: 0.086
  26. Watkins AA, Parsons N, Shehata DG, Vigna C, Lagisetty K, Bonner S, Lopez E, Wilder FG, Stock CT, Moffatt-Bruce S, David EA, Mitchell JD, Habib RH, Servais EL. Race, Ethnicity, and Payor Status Impact the Surgical Approach and Postoperative Outcomes of Lung Cancer Among Patients Within the Society of Thoracic Surgeons General Thoracic Surgery Database. Ann Surg. 2026 Jul 01; 284(1):83-90.
    View in: PubMed
    Score: 0.085
  27. Woodard GA, Grau-Sepulveda M, Onaitis MW, Udelsman BV, David EA, Jacobs JP, Kosinski AS, Blasberg JD, Boffa DJ. Lobectomy vs Sublobar Resection in The Society of Thoracic Surgeons Database: Importance of Patient Factors and Lymph Node Evaluation. Ann Thorac Surg. 2025 05; 119(5):1071-1081.
    View in: PubMed
    Score: 0.084
  28. Antonoff MB, Mitchell KG, Kim SS, Salfity HV, Kotova S, Ripley RT, Neri AL, Sood P, Gandhi SG, Elamin YY, Donington JS, Jones DR, David EA, Swisher SG, Opitz I, Hayanga JWA, Rocco G. The Society of Thoracic Surgeons (STS) Clinical Practice Guideline on Surgical Management of Oligometastatic Non-small Cell Lung Cancer. Ann Thorac Surg. 2025 03; 119(3):495-508.
    View in: PubMed
    Score: 0.084
  29. Stuart CM, Mott NM, Bronsert MR, Randhawa SK, David EA, Mitchell JD, Meguid RA. The Association Between Sociodemographic Factors and Delays to Minimally Invasive Surgery for Stage IA-IIIA Non-small Cell Lung Cancer. Ann Thorac Surg. 2025 05; 119(5):1082-1091.
    View in: PubMed
    Score: 0.084
  30. Brown LM, Bonnell L, Parsons N, Cooke DT, Godoy LA, David EA, Schipper P, Varghese TK, Habib R, Mitzman B. Predictors of Discharge With Supplemental Oxygen After Lobectomy for Lung Cancer. Ann Thorac Surg. 2025 01; 119(1):180-189.
    View in: PubMed
    Score: 0.082
  31. Stuart CM, Dyas AR, Bronsert MR, Velopulos CG, Randhawa SK, David EA, Mitchell JD, Meguid RA. The Effect of Social Vulnerability on Initial Stage and Treatment for Non-Small Cell Lung Cancer. Lung Cancer. 2024 02; 188:107452.
    View in: PubMed
    Score: 0.078
  32. Dyas AR, Bronsert MR, Stuart CM, Thomas MB, Schulick RD, Franco SR, Gleisner A, Randhawa SK, David EA, Mitchell JD, Meguid RA. Analyzing the impact of the Coronavirus disease 2019 pandemic on initial oncologic presentation and treatment of non-small cell lung cancer in the United States. J Thorac Cardiovasc Surg. 2024 08; 168(2):378-390.e7.
    View in: PubMed
    Score: 0.078
  33. Kidane B, Bott M, Spicer J, Backhus L, Chaft J, Chudgar N, Colson Y, D'Amico TA, David E, Lee J, Najmeh S, Sepesi B, Shu C, Yang J, Swanson S, Stiles B. The American Association for Thoracic Surgery (AATS) 2023 Expert Consensus Document: Staging and multidisciplinary management of patients with early-stage non-small cell lung cancer. J Thorac Cardiovasc Surg. 2023 09; 166(3):637-654.
    View in: PubMed
    Score: 0.075
  34. Axtell AL, David EA, Block MI, Parsons N, Habib R, Muniappan A. Association Between Interstitial Lung Disease and Outcomes After Lung Cancer Resection. Ann Thorac Surg. 2023 09; 116(3):533-541.
    View in: PubMed
    Score: 0.075
  35. Kim AT, Ding L, Lee HB, Ashbrook MJ, Ashrafi A, Wightman SC, Atay SM, David EA, Harano T, Kim AW. Longer hospitalizations, more complications, and greater readmissions for patients with comorbid psychiatric disorders undergoing pulmonary lobectomy. J Thorac Cardiovasc Surg. 2024 04; 167(4):1502-1511.e11.
    View in: PubMed
    Score: 0.075
  36. Farias AJ, Chan E, Navarro S, David EA, Eguchi M, Cockburn M. Lung Cancer Mortality Racial/Ethnic Disparities in Patient Experiences with Care: a SEER-CAHPS Study. J Racial Ethn Health Disparities. 2023 08; 10(4):1745-1755.
    View in: PubMed
    Score: 0.071
  37. Wightman SC, Lee JY, Ding L, Atay SM, Shemanski KA, McFadden PM, David EA, Kim AW. Adjuvant chemotherapy for visceral pleural invasion in 3-4-cm non-small-cell lung cancer improves survival. Eur J Cardiothorac Surg. 2022 06 15; 62(1).
    View in: PubMed
    Score: 0.070
  38. Jang JK, Atay SM, Ding L, David EA, Wightman SC, Kim AW, Ye JC. Patterns of Use of Stereotactic Body Radiation Therapy Compared With Surgery for Definitive Treatment of Primary Early-stage Non-small Cell Lung Cancer. Am J Clin Oncol. 2022 04 01; 45(4):146-154.
    View in: PubMed
    Score: 0.069
  39. Daly ME, Singh N, Ismaila N, Antonoff MB, Arenberg DA, Bradley J, David E, Detterbeck F, Früh M, Gubens MA, Moore AC, Padda SK, Patel JD, Phillips T, Qin A, Robinson C, Simone CB. Management of Stage III Non-Small-Cell Lung Cancer: ASCO Guideline. J Clin Oncol. 2022 04 20; 40(12):1356-1384.
    View in: PubMed
    Score: 0.068
  40. Peng T, Yau A, Ding L, David EA, Wightman SC, Atay SM, Kim AW. Primary signet ring cell histology does not portend worse survival for early stage lung cancer following lobectomy. Asian Cardiovasc Thorac Ann. 2022 Feb; 30(2):185-189.
    View in: PubMed
    Score: 0.067
  41. Atay SM, Amini M, Ding L, David EA, Mcfadden PM, Wightman SC, Kim AW. Adjuvant Chemotherapy Improves Survival in pN-positive Clinical Stage IIIA Non-Small Cell Lung Cancer After Neoadjuvant Therapy and Resection. Ann Thorac Surg. 2021 07; 112(1):197-205.
    View in: PubMed
    Score: 0.063
  42. Zhao J, Nguyen A, Ding L, David EA, Atay SM, Wightman SC, McFadden PM, Kim AW. Trends in pneumonectomy for treatment of small-cell lung cancer. Asian Cardiovasc Thorac Ann. 2020 Nov; 28(9):583-591.
    View in: PubMed
    Score: 0.062
  43. Xu E, David EA, Ding L, Atay SM, McFadden PM, Wightman SC, Kim AW. Sequence of biologic therapies and surgery affects survival in non-small cell lung cancer. J Surg Oncol. 2020 Aug; 122(2):320-327.
    View in: PubMed
    Score: 0.061
  44. Bateni SB, David EA, Bold RJ, Cooke DT, Meyers FJ, Canter RJ. Lung resection is safe and feasible among stage IV cancer patients: An American College of Surgeons National Surgical Quality Improvement Program analysis. Surgery. 2017 05; 161(5):1307-1314.
    View in: PubMed
    Score: 0.048
  45. Gandara DR, Mack PC, Bult C, Li T, Lara PN, Riess JW, Astrow SH, Gandour-Edwards R, Cooke DT, Yoneda KY, Moore EH, Pan CX, Burich RA, David EA, Keck JG, Airhart S, Goodwin N, de Vere White RW, Liu ET. Bridging tumor genomics to patient outcomes through an integrated patient-derived xenograft platform. Clin Lung Cancer. 2015 May; 16(3):165-72.
    View in: PubMed
    Score: 0.043
  46. Hayes JT, David EA, Qi L, Chen AM, Daly ME. Risk of Pneumonitis After Stereotactic Body Radiation Therapy in Patients With Previous Anatomic Lung Resection. Clin Lung Cancer. 2015 Sep; 16(5):379-84.
    View in: PubMed
    Score: 0.042
  47. Gaffey AC, David EA, Marshall MB. Surgical palliation of previously resected thoracic sarcoma. Ann Thorac Surg. 2011 Apr; 91(4):e54-6.
    View in: PubMed
    Score: 0.032
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)